Clinical and Molecular Epidemiology of Escherichia coli Sequence Type 131 among Hospitalized Patients Colonized Intestinally with Fluoroquinolone-Resistant E. coli

Molecular Epidemiology of Escherichia coli Sequence Type 131 and Its H30 and H30-Rx Subclones among Extended-Spectrum-β-Lactamase-Positive and -Negative E. coli Clinical Isolates from the Chicago Region, 2007 to 2010

(2013) Ritu Banerjee et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Editorial Commentary: Flying Under the Radar: The Stealth Pandemic of Escherichia coli Sequence Type 131

(2013) E. Lautenbach   CLINICAL INFECTIOUS DISEASES

Escherichia coli Sequence Type 131 (ST131) Subclone H30 as an Emergent Multidrug-Resistant Pathogen Among US Veterans

(2013) Aylin Colpan et al.   CLINICAL INFECTIOUS DISEASES

Escherichia coli Sequence Type 131 Is a Dominant, Antimicrobial-Resistant Clonal Group Associated with Healthcare and Elderly Hosts

(2013) Ritu Banerjee et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli

(2013) James R. Johnson et al.   JOURNAL OF INFECTIOUS DISEASES

The Epidemic of Extended-Spectrum- -Lactamase-Producing Escherichia coli ST131 Is Driven by a Single Highly Pathogenic Subclone, H30-Rx

(2013) L. B. Price et al.   mBio

Risk Factors for Efflux Pump Overexpression in Fluoroquinolone-Resistant Escherichia coli

(2012) J. H. Han et al.   JOURNAL OF INFECTIOUS DISEASES

The CTX-M-15-Producing Escherichia coli Clone O25b: H4-ST131 Has High Intestine Colonization and Urinary Tract Infection Abilities

(2012) Sophie Vimont et al.   PLoS One

Bacteremia Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli Sequence Type ST131 and Non-ST131 Clones: Comparison of Demographic Data, Clinical Features, and Mortality

(2011) Hsing-Chun Chung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States

(2010) James R. Johnson et al.   CLINICAL INFECTIOUS DISEASES

Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4

(2010) Gisele Peirano et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain

(2010) B. A. Rogers et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004

(2009) J. R. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Gastrointestinal Tract Colonization With Fluoroquinolone-Resistant Escherichia coli in Hospitalized Patients: Changes Over Time in Risk Factors for Resistance

(2008) Ebbing Lautenbach et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup

(2008) Olivier Clermont et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY